Stage IVB Prostate Cancer AJCC v8 Clinical Trials in Fargo, North Dakota

4 studies are recruiting for stage ivb prostate cancer ajcc v8 in Fargo, North Dakota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

   This phase II trial studies how well cabozantinib works in combination with nivolumab and ipilimumab in treating patients with rare genitourinary (GU) tumors that has spread from where it first started (primary site) to other places in the body. Cabozantinib may stop the growth of tumor cells by bl…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota

   Locations

   581 in total

   Run by

   National Cancer Institute (NCI)

   See if you can join NCT03866382 on ClinicalTrials.gov

2. Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial

   This phase II trial evaluates whether genetic testing in prostate cancer is helpful in deciding which study treatment patients are assigned. Patient cancer tissue samples are obtained from a previous surgery or biopsy procedure and tested for deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) a…

   Stage

   Phase 2

   Ages

   18 and older

   Site

   Essentia Health Cancer Center-South University Clinic, Fargo, North Dakota

   Locations

   108 in total

   Run by

   Alliance for Clinical Trials in Oncology

   See if you can join NCT06632977 on ClinicalTrials.gov

3. Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

   This phase III trial compares the effect of adding docetaxel to hormonal therapy and apalutamide versus hormonal therapy and apalutamide alone in treating patients with prostate cancer that has spread from where it first started (primary site) to other places in the body (metastatic). Docetaxel is …

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Sanford Broadway Medical Center, Fargo, North Dakota

   Locations

   210 in total

   Run by

   Alliance for Clinical Trials in Oncology

   See if you can join NCT06931340 on ClinicalTrials.gov

4. Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial

   This randomized phase III trial examines whether lengthening the dosage interval in an adaptive manner for the prostate cancer drug lutetium 177 Lu PSMA RLT improves quality of life without decreasing lifespan when compared to the standard way this medication is given. This study is for patients wi…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Sanford Broadway Medical Center, Fargo, North Dakota

   Locations

   129 in total

   Run by

   Alliance for Clinical Trials in Oncology

   See if you can join NCT07200830 on ClinicalTrials.gov